当前我国医药行业并购重组现状及对策研究分析【摘要】近年来，伴随国内医药市场竞争的日趋激烈，国内医药企业对金融资本的渴求达到了空前的水平，广开门路谋求并购重组带来的金融资本支持成为了医药企业做强做大的必然发展趋势。本文将基于博弈论分析法、案例分析法以及文献研究法探究关于当前我国医药行业并购重组的动因和现状，结果表明并购重组是企业发展成长、优化资源分配和实现规模经济的重要手段，也是助推经济增长和繁荣的重要驱动力。在我国医药行业并购市场积极活跃、海外并购火热、跨界并购升温、研发技能强的企业成为并购焦点和设立基金实现并购逐渐踊跃的同时存在着盲目并购导致的整合困难、信息不对称导致的资金链断裂以及各并购主体之间的利益冲突问题。继而针对性地给出提高我国医药行业并购重组效率的系统的、有效的、创新的对策，政府应强化监管与指导、医药企业明确自身的战略目标、注重并购前的预备工作以及有效整合和利用资源。最后对于其发展趋势展开预测，未来政府在药企并购中的作用将更加突出、医药并购更加青睐于新药研发企业、海外并购更加理性深入以及医药企业将朝着多元化方向发展。【关键词】医药行业；并购重组；动因；现状；对策建议注：本论文（设计）题目来源于教师的国家级（或省部级、厅级、市级、校级、企业）科研项目，项目编号为： 。Research and Analysis on the Status Quo and Countermeasures of Mergers and Acquisitions in China's Pharmaceutical Industry[Abstract] In recent years, with the increasingly fierce competition in the domestic pharmaceutical market, the thirst for financial capital of domestic pharmaceutical enterprises has reached an unprecedented level, and it has become an inevitable trend for pharmaceutical enterprises to become stronger and bigger to seek financial capital support brought by mergers and acquisitions. Based on the game theory analysis method, case analysis method and literature research method, this paper will explore the motivation and current situation of mergers and acquisitions in China's pharmaceutical industry. The results show that mergers and acquisitions are an important m...
